Research map: Insights from a Danish nationwide implementation of patient-reported outcomes in multiple sclerosis

Back to the article

Papers in this map

  1. The Multiple Sclerosis Impact Scale (MSIS-29): A new patient-based outcome measure · JC Hobart · 2001 · 1147 citations · Cited by this paper
  2. Comorbidities in newly diagnosed multiple sclerosis patients: A population-based register study in Finland · 2026 · Related
  3. Barriers and facilitators to utilizing digital health technologies by healthcare professionals · Israel Júnior Borges do Nascimento · 2023 · 692 citations · Cited by this paper
  4. Hypogammaglobulinemia and infection rates in patients with multiple sclerosis treated with ocrelizumab for up to six years: A real-world single-center study · 2025 · Related
  5. Assessment of lesions on magnetic resonance imaging in multiple sclerosis: practical guidelines · Massimo Filippi · 2019 · 573 citations · Cited by this paper
  6. Real-world safety and effectiveness of ofatumumab in multiple sclerosis: A clinic-based study in Australia · 2026 · Related
  7. Quantitative magnetic resonance imaging towards clinical application in multiple sclerosis · Cristina Granziera · 2021 · 209 citations · Cited by this paper
  8. Men's health research priorities in men with multiple sclerosis · 2026 · Related
  9. Clinical Utility and User Perceptions of a Digital System for Electronic Patient-Reported Symptom Monitoring During Routine Cancer Care: Findings From the PRO-TECT Trial · Ethan Basch · 2020 · 202 citations · Cited by this paper
  10. Music therapy with a monochord in multiple sclerosis (“MUTIMS”): A randomized, controlled, rater-blinded trial · 2025 · Related
  11. Outcome Measures in Clinical Trials for Multiple Sclerosis · Caspar E.P. van Munster · 2017 · 201 citations · Cited by this paper
  12. Deep cervical lymph node volume decreases following B-cell depletion therapy · 2025 · Related
  13. The state of multiple sclerosis: current insight into the patient/health care provider relationship, treatment challenges, and satisfaction · Mar Tintoré · 2016 · 81 citations · Cited by this paper
  14. Establishing demographic-based normative values for neurofilament light chain and glial fibrillary acidic protein in serum and plasma samples · 2026 · Related
  15. Evolution of Patient-Reported Outcomes and Their Role in Multiple Sclerosis Clinical Trials · Cindy J. Nowinski · 2017 · 73 citations · Cited by this paper
  16. Feasibility and preliminary outcomes of a remotely-delivered exercise training intervention for English-speaking Hispanics/Latinos with multiple sclerosis: Results from the FERLA MS study · 2026 · Related
  17. The association between patient-reported outcomes (PROs) and patient participation in chronic care: A scoping review · Jeppe Eriksen · 2022 · 46 citations · Cited by this paper
  18. Discrepancy between subjective and objective cognitive function in multiple sclerosis and association with mood, fatigue, and pain · 2026 · Related
  19. An overview of Personalized Medicine landscape and policies in the European Union · Flavia Beccia · 2022 · 36 citations · Cited by this paper
  20. Baricitinib triggering a central nervous system inflammatory-demyelinating disease: A case report · 2026 · Related
  21. Standardizing fatigue measurement in multiple sclerosis: the validity, responsiveness and score interpretation of the PROMIS SF v1.0 – Fatigue (MS) 8a · Paul Kamudoni · 2021 · 32 citations · Cited by this paper
  22. Patient perspectives on patient-reported outcomes in multiple sclerosis treatment trajectories: A qualitative study of why, what, and how? · Katrine Westergaard · 2021 · 30 citations · Cited by this paper
  23. Multiple sclerosis in Denmark (1950–2023): mean age, sex distribution, incidence and prevalence · Rolf Pringler Holm · 2024 · 23 citations · Cited by this paper
  24. A comparison of the measurement properties of the PROMIS Fatigue (MS) 8a against legacy fatigue questionnaires · Paul Kamudoni · 2022 · 22 citations · Cited by this paper
  25. Advanced MRI Techniques: Diagnosis and Follow-Up of Multiple Sclerosis · Riccardo Nistri · 2024 · 20 citations · Cited by this paper
  26. Insights for Healthcare Providers on Shared Decision-Making in Multiple Sclerosis: A Narrative Review · Sharon S. Stoll · 2024 · 12 citations · Cited by this paper
  27. Evaluation of Patient-Reported Outcomes in Patients with Relapsing Multiple Sclerosis Treated with Cladribine Tablets in the CLAWIR Study: 12-Month Interim Analysis · Daniela Rau · 2023 · 6 citations · Cited by this paper
  28. Patient-Generated Data as Indicators of Impact of Multidisciplinary and Multi-stakeholder Health Care Systems, in the Age of Personalised Medicine · Paola Zaratin · 2025 · 4 citations · Cited by this paper
  29. Untitled · Cited by this paper
  30. Untitled · Cited by this paper

Source: OpenAlex (CC0)